BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

GenNext Technologies and Agilent Partner to Transform Protein Structure Analysis in Biopharma Research

GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural biology research for biopharmaceutical companie...

September 12, 2024 | News

MGI Introduces CycloneSEQ-WT02 and CycloneSEQ-WY01, Advancing High-Throughput Nanopore Sequencing

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced the global r...

September 10, 2024 | Product Spotlight

Janssen-Cilag International Announces Superior Long-Term Outcomes of Amivantamab Plus Lazertinib from MARIPOSA Study

Janssen-Cilag International NV, a Johnson & Johnson company, announced new longer follow-up data from the landmark Phase 3 MARIPOSA study. These ...

September 09, 2024 | News

Antabio Completes Phase 1 Trial of MEM-ANT3310, Advancing Novel Antibacterial Treatment for Drug-Resistant Infections

Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a pa...

September 06, 2024 | News

Sanyou Biopharmaceuticals Introduces Comprehensive Monkeypox Product Line Featuring Antigens, Monoclonal Antibodies, and Overexpression Cell Lines

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced the launch of a comprehensive product line targeting monkeypox, which includes antigens, monoclona...

September 02, 2024 | News

HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage

A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...

August 28, 2024 | News

Alzheimer's Association Applauds U.K.'s Approval of Leqembi® Amidst Concerns Over NHS Access Denial

The Alzheimer's Association welcomes decision by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqem...

August 23, 2024 | News

Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development

Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...

August 19, 2024 | News

Sanyou Biopharmaceuticals Launches Cutting-Edge "oneClick+" Platform for Intelligent Antibody Design

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. officially announced the launch of the "Sanyou Innovative Intelligent Antibody Design oneClick+ Platform." ...

August 16, 2024 | News

Beckman Coulter Life Sciences and Illumina Launch Automated Solution for Faster, Comprehensive Oncology Genomic Profiling

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA...

August 07, 2024 | News

Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...